Author:
KOPYTIN I.A., ,IVANOV V.V.,FILIMONOV V.B.,ZHURAVLYOV G.Y.,FOMIN V.S.,ABRAMOV I.V., , , , ,
Abstract
Methods: The relevance of nonparasitic cysts of the liver (NPCL) is related to their steadily increasing incidence, high recurrence rates, delayed diagnosis, and potential complications. In general, hepatic cysts (HCs) are classified into several types, including simple and complex, false and true. Simple cysts are mainly congenital but also occur in polycystic liver disease. Complex cysts include mucinous neoplasms, echinococcal cysts, hemorrhagic cysts, cystic hepatocellular carcinoma, and other rare lesions. Nonparasitic cystic liver lesions do not usually cause symptoms, and their characteristics are not specific. In 15% of cases, nonspecific signs (flatulence, nausea, dyspepsia) accompany pain. Diagnosis of NPCL is based on data from ultrasound, CT, or MRI of the abdominal organs. There still needs to be a consensus on surgical treatment indications or the effectiveness and feasibility of its various methods. Many surgical interventions for NPCL treatment include puncture drainage, multiple minimally invasive (laparoscopic) surgery options, and open methods. In clinical practice, laparoscopic fenestration, associated with fewer complications and faster recovery, has become widespread. However, significant progress has yet to be achieved in reducing NPCL recurrence rates despite advances in surgical treatment. Therefore, multiple studies are underway to improve treatment options for this medical condition. Keywords: Liver, cyst, nonparasitic cyst, pseudocyst, laparoscopic fenestration.
Publisher
Avicenna Tajik State Medical University
Subject
Psychiatry and Mental health
Reference41 articles.
1. 1. Zarivchatskiy MF, Pankov KI, Kamenskikh ED, Mugatarov II, Smetanin DV. Mini-invazivnye tekhnologii pri lechenii neparazitarnykh kist pecheni [Mini-invasive techniques in treatment of nonparasitic hepatic cysts]. Permskiy meditsinskiy zhurnal. 2013;30(1):5-10
2. 2. Dietrich CF, Chiorean L, Potthoff A, Ignee A, Cui X, Sparchez Z. Percutaneous sclerotherapy of liver and renal cysts, comments on the EFSUMB guidelines. Z Gastroenterol. 2016;54(2):155-66. https://doi.org/10.1055/s-0041-106594
3. 3. Alshaikhli A, Al-Hillan A. Liver Cystic Disease. 2022 Oct 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan
4. 4. Lasagni A, Cadamuro M, Morana G, Fabris L, Strazzabosco M. Fibrocystic liver disease: Novel concepts and translational perspectives. Transl Gastroenterol Hepatol. 2021;6:26. https://doi.org/10.21037/tgh-2020-04
5. 5. Murunova YuN, Darvin VV. Lechebno-diagnosticheskaya taktika vedeniya patsientov s neparazitarnymi kistami pecheni [Therapeutic and diagnostic tactics for the management of patients with non-parasitic liver cysts]. Ural'skiy meditsinskiy zhurnal. 2018;(12):136-40. https://doi.org/10.25694/ URMJ.2018.12.37